Cargando…

PET measurement of cyclooxygenase-2 using a novel radioligand: upregulation in primate neuroinflammation and first-in-human study

BACKGROUND: Cyclooxygenase-2 (COX-2), which is rapidly upregulated by inflammation, is a key enzyme catalyzing the rate-limiting step in the synthesis of several inflammatory prostanoids. Successful positron emission tomography (PET) radioligand imaging of COX-2 in vivo could be a potentially powerf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shrestha, Stal, Kim, Min-Jeong, Eldridge, Mark, Lehmann, Michael L., Frankland, Michael, Liow, Jeih-San, Yu, Zu-Xi, Cortes-Salva, Michelle, Telu, Sanjay, Henter, Ioline D., Gallagher, Evan, Lee, Jae-Hoon, Fredericks, J. Megan, Poffenberger, Chelsie, Tye, George, Ruiz-Perdomo, Yanira, Anaya, Fernanda Juarez, Montero Santamaria, Jose A., Gladding, Robert L., Zoghbi, Sami S., Fujita, Masahiro, Katz, James D., Pike, Victor W., Innis, Robert B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195739/ https://www.ncbi.nlm.nih.gov/pubmed/32359360 http://dx.doi.org/10.1186/s12974-020-01804-6

Ejemplares similares

2-(4-Methylsulfonylphenyl)pyrimidines as Prospective Radioligands for Imaging Cyclooxygenase-2 with PET—Synthesis, Triage, and Radiolabeling
por: Cortes-Salva, Michelle Y., et al.
Publicado: (2018)

Candidate 3-benzazepine-1-ol type GluN2B receptor radioligands ((11)C-NR2B-Me enantiomers) have high binding in cerebellum but not to σ1 receptors
por: Cai, Lisheng, et al.
Publicado: (2023)

(11)C-LY2428703, a positron emission tomographic radioligand for the metabotropic glutamate receptor 1, is unsuitable for imaging in monkey and human brains
por: Zanotti-Fregonara, Paolo, et al.
Publicado: (2013)

[O-methyl-(11)C]N-(4-(4-(3-Chloro-2-methoxyphenyl)-piperazin-1-yl)butyl)-1H-indole-2-carboxamide ([(11)C]BAK4-51) Is an Efflux Transporter Substrate and Ineffective for PET Imaging of Brain D(3) Receptors in Rodents and Monkey
por: Liow, Jeih-San, et al.
Publicado: (2018)

Human Biodistribution and Dosimetry of (11)C-CUMI-101, an Agonist Radioligand for Serotonin-1A Receptors in Brain
por: Hines, Christina S., et al.
Publicado: (2011)

Region- and voxel-based quantification in human brain of [(18)F]LSN3316612, a radioligand for O-GlcNAcase
por: Lee, Jae-Hoon, et al.
Publicado: (2021)

In vivo evaluation of a novel (18)F-labeled PET radioligand for translocator protein 18 kDa (TSPO) in monkey brain
por: Yan, Xuefeng, et al.
Publicado: (2023)

Development of N-Methyl-(2-arylquinolin-4-yl)oxypropanamides as Leads to PET Radioligands for Translocator Protein (18 kDa)
por: Brouwer, Chad, et al.
Publicado: (2014)

PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects
por: Richards, Erica M., et al.
Publicado: (2018)

Synthesis and Evaluation of Translocator 18 kDa Protein (TSPO) Positron Emission Tomography (PET) Radioligands with Low Binding Sensitivity to Human Single Nucleotide Polymorphism rs6971
por: Zanotti-Fregonara, Paolo, et al.
Publicado: (2014)

Image-Derived Input Function for Human Brain Using High Resolution PET Imaging with [(11)C](R)-rolipram and [(11)C]PBR28
por: Zanotti-Fregonara, Paolo, et al.
Publicado: (2011)

Image-Derived Input Function Derived from a Supervised Clustering Algorithm: Methodology and Validation in a Clinical Protocol Using [(11)C](R)-Rolipram
por: Lyoo, Chul Hyoung, et al.
Publicado: (2014)

Fluorine-18 Labelled Radioligands for PET Imaging of Cyclooxygenase-2
por: Kaur, Jatinder, et al.
Publicado: (2022)

Population-Based Input Function Modeling for [(18)F]FMPEP-d (2), an Inverse Agonist Radioligand for Cannabinoid CB(1) Receptors: Validation in Clinical Studies
por: Zanotti-Fregonara, Paolo, et al.
Publicado: (2013)

PET quantification of brain O-GlcNAcase with [(18)F]LSN3316612 in healthy human volunteers
por: Lee, Jae-Hoon, et al.
Publicado: (2020)

Comparison of four (11)C-labeled PET ligands to quantify translocator protein 18 kDa (TSPO) in human brain: (R)-PK11195, PBR28, DPA-713, and ER176—based on recent publications that measured specific-to-non-displaceable ratios
por: Fujita, Masahiro, et al.
Publicado: (2017)

cAMP Signaling in Brain is Decreased in Unmedicated Depressed Patients and Increased by Treatment with a Selective Serotonin Reuptake Inhibitor
por: Fujita, Masahiro, et al.
Publicado: (2016)

The neurotrophic and neuroprotective effects of psychotropic agents
por: Hunsberger, Joshua, et al.
Publicado: (2009)

Ketamine treatment for depression: a review
por: Yavi, Mani, et al.
Publicado: (2022)

Metal-Based PSMA Radioligands
por: Gourni, Eleni, et al.
Publicado: (2017)

Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
por: Kadriu, Bashkim, et al.
Publicado: (2018)

A wake-up call: Sleep physiology and related translational discrepancies in studies of rapid-acting antidepressants
por: Alitalo, Okko, et al.
Publicado: (2021)

Microglial CSF1R radioligand [(11)C]CPPC as a marker of disease severity in early Parkinson’s disease: a pilot study
por: Mills, Kelly A., et al.
Publicado: (2023)

Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder
por: Machado-Vieira, Rodrigo, et al.
Publicado: (2023)

Editorial: Response assessment of radioligand therapies
por: Lopci, Egesta, et al.
Publicado: (2022)

Development of a non-radiometric method for measuring the arterial input function of a (11)C-labeled PET radiotracer
por: Shetty, H. Umesha, et al.
Publicado: (2020)

Radioligands Targeting Fibroblast Activation Protein (FAP)
por: Lindner, Thomas, et al.
Publicado: (2021)

Pharmacological Optimization of PSMA-Based Radioligand Therapy
por: van der Gaag, Suzanne, et al.
Publicado: (2022)

Commercial and business aspects of alpha radioligand therapeutics
por: Ostuni, Emanuele, et al.
Publicado: (2023)

Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists
por: Nock, Berthold A., et al.
Publicado: (2023)

The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments
por: Machado-Vieira, Rodrigo, et al.
Publicado: (2010)

Radiosynthesis and in Vivo Evaluation of Two PET Radioligands for Imaging α-Synuclein
por: Zhang, Xiang, et al.
Publicado: (2014)

Differential gene expression patterns in cyclooxygenase-1 and cyclooxygenase-2 deficient mouse brain
por: Toscano, Christopher D, et al.
Publicado: (2007)

The cyclooxygenases
por: Chandrasekharan, NV, et al.
Publicado: (2004)

A novel antioxidant ergothioneine PET radioligand for in vivo imaging applications
por: Behof, William J., et al.
Publicado: (2021)

PET Reveals Inflammation around Calcified Taenia solium Granulomas with Perilesional Edema
por: Fujita, Masahiro, et al.
Publicado: (2013)

Radioligand therapies in cancer: mapping the educational landscape in Europe
por: Bugani, Valentina, et al.
Publicado: (2023)

Development of a PET radioligand for potassium channels to image CNS demyelination
por: Brugarolas, Pedro, et al.
Publicado: (2018)

Are 24-hour motor activity patterns associated with continued rapid response to ketamine?
por: Duncan, Wallace C, et al.
Publicado: (2018)

The Evaluation of Dynamic FDG-PET for Detecting Epileptic Foci and Analyzing Reduced Glucose Phosphorylation in Refractory Epilepsy
por: Tang, Yongxiang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pko7miu98gai2dllsjtjcvk10i